M Ojima

452 total citations
9 papers, 409 citations indexed

About

M Ojima is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, M Ojima has authored 9 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Molecular Biology. Recurrent topics in M Ojima's work include Blood Pressure and Hypertension Studies (4 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). M Ojima is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). M Ojima collaborates with scholars based in Japan. M Ojima's co-authors include Yumiko Shibouta, Takehiko Naka, Tsukasa Sanada, Yasuhiro Inada, Yasuhisa Kohara, Keiji Kubo, Takeo Wada, Kohei Nishikawa, Makoto Noda and Takao Wada and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry Letters and Journal of Human Hypertension.

In The Last Decade

M Ojima

9 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ojima Japan 6 302 167 166 41 35 9 409
Tsukasa Sanada Japan 9 345 1.1× 215 1.3× 197 1.2× 45 1.1× 46 1.3× 13 491
K Takeuchi Japan 7 237 0.8× 227 1.4× 150 0.9× 59 1.4× 33 0.9× 21 434
P C Wong United States 8 343 1.1× 294 1.8× 181 1.1× 42 1.0× 73 2.1× 10 579
R S Chang United States 9 284 0.9× 240 1.4× 135 0.8× 33 0.8× 54 1.5× 9 478
Gérard Barthélémy France 5 174 0.6× 115 0.7× 69 0.4× 21 0.5× 31 0.9× 8 266
Kumiko Shiono Japan 9 184 0.6× 147 0.9× 106 0.6× 26 0.6× 56 1.6× 15 414
Rose Perich Australia 10 234 0.8× 117 0.7× 103 0.6× 30 0.7× 35 1.0× 19 347
Delores J. Blehm United States 11 190 0.6× 94 0.6× 82 0.5× 41 1.0× 24 0.7× 12 357
Lucia Turolo Italy 10 232 0.8× 84 0.5× 166 1.0× 26 0.6× 21 0.6× 27 400
Sergio Salardi Italy 10 118 0.4× 249 1.5× 159 1.0× 20 0.5× 22 0.6× 15 413

Countries citing papers authored by M Ojima

Since Specialization
Citations

This map shows the geographic impact of M Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ojima more than expected).

Fields of papers citing papers by M Ojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ojima. The network helps show where M Ojima may publish in the future.

Co-authorship network of co-authors of M Ojima

This figure shows the co-authorship network connecting the top 25 collaborators of M Ojima. A scholar is included among the top collaborators of M Ojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ojima. M Ojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ojima, M, et al.. (1999). Pharmacologic properties of candesartan cilexetil—possible mechanisms of long-acting antihypertensive action. Journal of Human Hypertension. 13(S1). S75–S80. 19 indexed citations
2.
Wada, Takao, M Ojima, Yumiko Shibouta, et al.. (1997). Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension. 19(7). 1079–1099. 91 indexed citations
3.
Wada, Takeo, et al.. (1997). Regional Hemodynamic Effects of Candesartan Cilexetil (TCV-116), an Angiotensin II AT1-Receptor Antagonist, in Conscious Spontaneously Hypertensive Rats. The Japanese Journal of Pharmacology. 73(3). 185–190. 2 indexed citations
4.
Ojima, M, et al.. (1995). Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.. PubMed. 21(2). 41–9. 9 indexed citations
5.
Nishikawa, Kohei, Yumiko Shibouta, Takao Wada, et al.. (1994). Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.. PubMed. 5. 7–14. 14 indexed citations
6.
Kubo, K., Shinichi Furuya, Yoshimi Sugiura, et al.. (1994). A new class of diacidic nonpeptide angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 35–40. 4 indexed citations
9.
Ojima, M, et al.. (1990). Delapril prevents stroke, renal dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. 18(6). 29–39. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026